Eltrombopag Taste Testing in Healthy Adult Volunteers

Completed · Phase 1

Conditions studied: Healthy Subjects, Purpura, Thrombocytopenic, Idiopathic

In brief

Based on a need for a pediatric formulation of eltrombopag for the treatment of pediatric thrombocytopenia, this study will help determine the best tasting pediatric formulation of eltrombopag. Healthy adult volunteers who are able to taste bitterness and who do not have a high sensitivity to bitterness will be enrolled. The subjects will evaluate different formulations and rate them based on the bitterness and effectiveness of sweetners. The outcome of this study will help support a decision for a new pediatric formulation of eltrombopag.

Key facts

Study ID

NCT00487968

Run by

GlaxoSmithKline

People needed

12

Starts

2007-05-01

Last updated by the study team

2012-03-19

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy adult based on a medical evaluation by a responsible physician
• male or female adult between 18 and 55 years old
• female subjects who are not pregnant or lactating
• females who are unable to have children must have documented medical verification
• females who are able to have children must have a negative pregnancy test
• capable of giving written informed consent

You may not qualify if…

• subjects who are unable to taste bitterness or are extrememly sensitive to bitterness
• participated in a clinical trial within 30 days
• exposure to more than four new medicines within 12 months prior to the first day of dosing
• history of sensitivity to any of the study medications

Where it is running

• GSK Investigational Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.